Published in Neurotherapeutics on October 01, 2009
Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology (2013) 2.26
CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety. Neuron (2015) 1.64
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care (2013) 1.62
Descending pain modulation and chronification of pain. Curr Opin Support Palliat Care (2014) 1.30
Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev (2012) 1.25
Rediscovery of nefopam for the treatment of neuropathic pain. Korean J Pain (2014) 1.17
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain. J Pain Res (2011) 1.08
Central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum (2013) 1.06
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats. J Pain Res (2012) 1.00
Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord. Neuropharmacology (2014) 1.00
Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy. J Pharmacol Exp Ther (2010) 0.88
Emotional modulation of pain and spinal nociception in persons with major depressive disorder (MDD). Pain (2013) 0.87
Recent advances in the treatment of pain. F1000 Med Rep (2010) 0.86
Cancer pain physiology. Br J Pain (2014) 0.84
[Nociceptive system : Nociceptors, fiber types, spinal pathways, and projection areas]. Schmerz (2010) 0.84
[Tapentadol: with two mechanisms of action in one molecule effective against nociceptive and neuropathic pain. Preclinical overview]. Schmerz (2011) 0.83
The antinociceptive effect of milnacipran in the monosodium iodoacetate model of osteoarthritis pain and its relation to changes in descending inhibition. J Pharmacol Exp Ther (2013) 0.81
Efficacy of Duloxetine in Patients with Chronic Pain Conditions. Curr Drug ther (2011) 0.81
The perception and endogenous modulation of pain. Scientifica (Cairo) (2012) 0.80
A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients. Arthritis Res Ther (2015) 0.80
Conditioned pain modulation in temporomandibular disorders (TMD) pain patients. Exp Brain Res (2014) 0.80
Is tapentadol different from classical opioids? A review of the evidence. Br J Pain (2016) 0.80
Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates. Daru (2014) 0.79
A pronociceptive role for the 5-HT2 receptor on spinal nociceptive transmission: an in vivo electrophysiological study in the rat. Brain Res (2011) 0.79
Imidazoline I2 receptors: An update. Pharmacol Ther (2017) 0.77
Predictors of duloxetine adherence and persistence in patients with fibromyalgia. J Pain Res (2012) 0.76
Evaluation of the analgesic effects of ammoxetine, a novel potent serotonin and norepinephrine reuptake inhibitor. Acta Pharmacol Sin (2016) 0.75
Electroacupuncture Pretreatment at GB20 Exerts Antinociceptive Effects via Peripheral and Central Serotonin Mechanism in Conscious Migraine Rats. Evid Based Complement Alternat Med (2016) 0.75
Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Ther Clin Risk Manag (2015) 0.75
Discordant Dry Eye Disease (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc (2016) 0.75
The analgesic effect of different antidepressants combined with aspirin on thermally induced pain in Albino mice. Libyan J Med (2012) 0.75
Chronic constriction injury of sciatic nerve changes circular RNA expression in rat spinal dorsal horn. J Pain Res (2017) 0.75
[Prolonged-release tapentadol for phantom pain. A case series]. Schmerz (2013) 0.75
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
Pain mechanisms: a new theory. Science (1965) 24.47
Depression and pain comorbidity: a literature review. Arch Intern Med (2003) 11.34
Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs. Nature (1985) 4.72
COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science (2003) 4.72
State-dependent opioid control of pain. Nat Rev Neurosci (2004) 3.51
Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain (1988) 3.06
Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med (1992) 2.96
Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain (1999) 2.77
Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci (1995) 2.62
Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science (1999) 2.43
Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature (1988) 2.42
Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci (1991) 2.35
Central influences on spinal afferent conduction. J Neurophysiol (1954) 2.27
Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci (2002) 2.24
5-HT3 receptors are membrane ion channels. Nature (1989) 2.21
Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain (2001) 2.05
Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proc Natl Acad Sci U S A (2008) 2.04
Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci (2002) 2.00
Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med (2001) 1.94
Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol (2003) 1.94
Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance? Neurosignals (2005) 1.80
Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci (2001) 1.76
Neurokinin 1 receptor expression by neurons in laminae I, III and IV of the rat spinal dorsal horn that project to the brainstem. Eur J Neurosci (2000) 1.75
(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther (2007) 1.72
Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci (2001) 1.72
Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci (2000) 1.71
Observations on the scratch-reflex in the spinal dog. J Physiol (1906) 1.70
Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol (2003) 1.69
The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heat. J Neurosci (1983) 1.69
Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans. Proc Natl Acad Sci U S A (2005) 1.65
Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol (2005) 1.58
Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science (1991) 1.55
Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin. Pain (2005) 1.54
Peripheral neuropathic pain--a multidimensional burden for patients. Eur J Pain (2001) 1.46
Brainstem control of spinal pain-transmission neurons. Annu Rev Physiol (1978) 1.45
Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J Pharmacol Exp Ther (1987) 1.42
Anatomy and physiology of a nociceptive modulatory system. Philos Trans R Soc Lond B Biol Sci (1985) 1.39
Descending facilitation from the rostral ventromedial medulla maintains visceral pain in rats with experimental pancreatitis. Gastroenterology (2006) 1.34
Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci (2000) 1.33
Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices. Pain (2001) 1.30
Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci (2005) 1.29
Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs. J Neurosci (2007) 1.26
Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res (2004) 1.26
Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain (2004) 1.26
Sensitization of pain-modulating neurons in the rostral ventromedial medulla after peripheral nerve injury. J Neurosci (2007) 1.25
Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain (1988) 1.25
Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin. Pain (2008) 1.25
Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla. Neuroscience (1994) 1.24
Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor. Nature (1997) 1.24
Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain. Pain (2003) 1.24
Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain (2000) 1.23
Does a single intravenous injection of the 5HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled cross-over study. Anesth Analg (2003) 1.19
Neurokinin-1 receptors on lumbar spinothalamic neurons in the rat. Neuroscience (1996) 1.19
Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation. Pain (2006) 1.17
Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways. Pain (2006) 1.15
Dual effect of serotonin on formalin-induced nociception in the rat spinal cord. Neurosci Res (1996) 1.13
The anatomy of brain stem pathways to the spinal cord in cat. A labeled amino acid tracing study. Prog Brain Res (1982) 1.13
Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci Lett (2005) 1.13
Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. Br J Pharmacol (2005) 1.11
The origin of brainstem noradrenergic and serotonergic projections to the spinal cord dorsal horn in the rat. Somatosens Mot Res (1992) 1.10
Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward. Proc Natl Acad Sci U S A (2007) 1.09
Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J Neurosci (2002) 1.09
Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res (1979) 1.08
Putative pain modulating neurons in the rostral ventral medulla: reflex-related activity predicts effects of morphine. Brain Res (1986) 1.08
The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury. Pain (2004) 1.08
Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation. Neuroreport (1997) 1.05
Attenuation of hyperalgesia in a rat model of neuropathic pain after intrathecal pre- or post-treatment with a neurokinin-1 antagonist. Pain (2002) 1.03
Rostral ventromedial medulla control of spinal sensory processing in normal and pathophysiological states. Neuroscience (2007) 1.02
Antidepressants for neuropathic pain. Cochrane Database Syst Rev (2005) 1.02
Activation of brainstem N-methyl-D-aspartate receptors is required for the analgesic actions of morphine given systemically. Pain (2001) 1.00
Pharmacologic evidence for the modulation of nociception by noradrenergic neurons. Prog Brain Res (1988) 0.98
5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord. Eur J Pharmacol (1989) 0.98
5-HT3 receptors in the rat central nervous system are mainly located on nerve fibres and terminals. Brain Res (1993) 0.98
Peripheral nerve injury-induced changes in spinal alpha(2)-adrenoceptor-mediated modulation of mechanically evoked dorsal horn neuronal responses. J Pain (2008) 0.96
Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury. Br J Pharmacol (2006) 0.95
Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats. Pain (2006) 0.94
Changes in AMPA receptor phosphorylation in the rostral ventromedial medulla after inflammatory hyperalgesia in rats. Neurosci Lett (2004) 0.93
Analgesic effects of serotonin and receptor-selective serotonin agonists in the rat spinal cord. Gen Pharmacol (1991) 0.93
Contribution of dopamine receptors to periaqueductal gray-mediated antinociception. Psychopharmacology (Berl) (2009) 0.93
Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain (2002) 0.93
Evidence of a role for descending serotonergic facilitation in a rat model of cancer-induced bone pain. Neurosci Lett (2005) 0.92
Pharmacological antagonism of the antinociceptive effects of serotonin in the rat spinal cord. Eur J Pharmacol (1983) 0.92
Opioid-activated postsynaptic, inward rectifying potassium currents in whole cell recordings in substantia gelatinosa neurons. J Neurophysiol (1998) 0.92
Descending serotonergic facilitation mediated through rat spinal 5HT3 receptors is unaltered following carrageenan inflammation. Neurosci Lett (2004) 0.91
[Pain in Parkinson's disease]. Rev Neurol (Paris) (2005) 0.90
Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain (2004) 0.90
Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain (1997) 0.90
Intrathecal serotonin in mice: analgesia and inhibition of a spinal action of substance P. Life Sci (1983) 0.90
A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist. Pain (2001) 0.89
Neurochemistry and neural circuitry in the dorsal horn. Prog Brain Res (1986) 0.89
Activation of serotonergic neurons in the raphe magnus is not necessary for morphine analgesia. J Neurosci (1998) 0.87
5-HT3 receptors modulate spinal nociceptive reflexes. Brain Res (1990) 0.87
Changes in expression of voltage-dependent ion channel subunits in dorsal root ganglia of rats with radicular injury and pain. Spine (Phila Pa 1976) (2002) 0.86
5-Hydroxytryptamine-facilitated release of substance P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP. J Neurochem (1997) 0.85
Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients. Am J Gastroenterol (2001) 0.85
Selective innervation of lamina I projection neurones that possess the neurokinin 1 receptor by serotonin-containing axons in the rat spinal cord. Neuroscience (2002) 0.84
The cell and molecular basis of mechanical, cold, and inflammatory pain. Science (2008) 3.46
Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A (2004) 3.07
KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci (2003) 2.40
Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat Neurosci (2002) 2.24
Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci (2004) 1.91
Gabapentin normalizes spinal neuronal responses that correlate with behavior in a rat model of cancer-induced bone pain. Anesthesiology (2005) 1.80
The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci (2009) 1.73
Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat Commun (2012) 1.72
Nociceptor-specific gene deletion using heterozygous NaV1.8-Cre recombinase mice. Pain (2005) 1.72
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care (2013) 1.62
Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain (2006) 1.61
Neural coding of nociceptive stimuli-from rat spinal neurones to human perception. Pain (2013) 1.54
Spinal-supraspinal serotonergic circuits regulating neuropathic pain and its treatment with gabapentin. Pain (2005) 1.54
Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients. Pain (2011) 1.49
Fibromyalgia: harmonizing science with clinical practice considerations. Pain Pract (2008) 1.38
Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions. J Neurosci (2008) 1.34
Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res (2004) 1.26
Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev (2012) 1.25
Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin. Pain (2008) 1.25
Animal models of bone cancer pain: systematic review and meta-analyses. Pain (2013) 1.22
Differential role of N-type calcium channel splice isoforms in pain. J Neurosci (2007) 1.22
Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain. Mol Pain (2009) 1.21
Pregabalin suppresses spinal neuronal hyperexcitability and visceral hypersensitivity in the absence of peripheral pathophysiology. Anesthesiology (2011) 1.21
Does a single intravenous injection of the 5HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled cross-over study. Anesth Analg (2003) 1.19
Formalin-induced behavioural hypersensitivity and neuronal hyperexcitability are mediated by rapid protein synthesis at the spinal level. Mol Pain (2009) 1.19
Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation. Pain (2006) 1.17
Combination pharmacotherapy for management of chronic pain: from bench to bedside. Lancet Neurol (2013) 1.14
Characterisation of a peripheral neuropathic component of the rat monoiodoacetate model of osteoarthritis. PLoS One (2012) 1.14
Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. Eur J Pain (2008) 1.12
Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior. J Neurosci (2006) 1.11
Mammalian target of rapamycin signaling in the spinal cord is required for neuronal plasticity and behavioral hypersensitivity associated with neuropathy in the rat. J Pain (2010) 1.09
Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain (2010) 1.06
Reference values of mechanical and thermal pain tests in a pain-free population. Eur J Pain (2010) 1.05
Opioid hyperalgesia. Curr Opin Support Palliat Care (2010) 1.04
Local and descending circuits regulate long-term potentiation and zif268 expression in spinal neurons. Eur J Neurosci (2006) 1.03
Behavioural and electrophysiological characterisation of experimentally induced osteoarthritis and neuropathy in C57Bl/6 mice. Mol Pain (2009) 1.03
A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy. Anesthesiology (2002) 1.03
Visceral pain: the ins and outs, the ups and downs. Curr Opin Support Palliat Care (2012) 1.02
A functional role for small-conductance calcium-activated potassium channels in sensory pathways including nociceptive processes. J Neurosci (2005) 1.01
Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy. Brain Res (2003) 1.01
Peripheral input and its importance for central sensitization. Ann Neurol (2013) 1.00
Oxytocin actions on afferent evoked spinal cord neuronal activities in neuropathic but not in normal rats. Brain Res (2005) 1.00
α2δ-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage. J Neurosci (2013) 0.98
The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain. Eur J Neurosci (2007) 0.96
Electrophysiological characterisations of rat lamina I dorsal horn neurones and the involvement of excitatory amino acid receptors. Pain (2004) 0.96
Peripheral nerve injury-induced changes in spinal alpha(2)-adrenoceptor-mediated modulation of mechanically evoked dorsal horn neuronal responses. J Pain (2008) 0.96
Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury. Exp Neurol (2005) 0.94
Specific involvement of atypical PKCζ/PKMζ in spinal persistent nociceptive processing following peripheral inflammation in rat. Mol Pain (2011) 0.93
The anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo. Biochem Soc Trans (2010) 0.93
Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain. Mol Ther (2011) 0.92
Evidence of a role for descending serotonergic facilitation in a rat model of cancer-induced bone pain. Neurosci Lett (2005) 0.92
Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat. Neuropeptides (2003) 0.91
The nociceptive withdrawal reflex: normative values of thresholds and reflex receptive fields. Eur J Pain (2009) 0.91
Enhanced pre-synaptic glutamate release in deep-dorsal horn contributes to calcium channel alpha-2-delta-1 protein-mediated spinal sensitization and behavioral hypersensitivity. Mol Pain (2009) 0.91
Descending serotonergic facilitation mediated through rat spinal 5HT3 receptors is unaltered following carrageenan inflammation. Neurosci Lett (2004) 0.91
Functional significance of M-type potassium channels in nociceptive cutaneous sensory endings. Front Mol Neurosci (2012) 0.90
A Selective Role for alpha3 Subunit Glycine Receptors in Inflammatory Pain. Front Mol Neurosci (2009) 0.90
In vivo electrophysiology of dorsal-horn neurons. Methods Mol Med (2004) 0.89
Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation. Eur J Neurosci (2012) 0.89
Mechanisms of pain in nonmalignant disease. Curr Opin Support Palliat Care (2008) 0.86
Nerve injury alters the effects of interleukin-6 on nociceptive transmission in peripheral afferents. Eur J Pharmacol (2004) 0.85
Efficacy of chronic morphine in a rat model of cancer-induced bone pain: behavior and in dorsal horn pathophysiology. J Pain (2005) 0.85
Pharmacological treatment of peripheral neuropathic pain conditions based on shared commonalities despite multiple etiologies. Pain (2005) 0.84
Na(v) 1.8-null mice show stimulus-dependent deficits in spinal neuronal activity. Mol Pain (2006) 0.84
The coding of noxious mechanical and thermal stimuli of deep dorsal horn neurones is attenuated in NK1 knockout mice. Neuropharmacology (2003) 0.84
Evidence for spinal dorsal horn hyperexcitability in rats following sustained morphine exposure. Neurosci Lett (2006) 0.83
Selective ablation of dorsal horn NK1 expressing cells reveals a modulation of spinal alpha2-adrenergic inhibition of dorsal horn neurones. Neuropharmacology (2008) 0.83
Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain. Neurosci Lett (2013) 0.83
Novel TRPM8 antagonist attenuates cold hypersensitivity after peripheral nerve injury in rats. J Pharmacol Exp Ther (2014) 0.82
Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations. Pain (2015) 0.82
Central neuronal mechanisms in cancer-induced bone pain. Curr Opin Support Palliat Care (2007) 0.81
The antinociceptive effect of milnacipran in the monosodium iodoacetate model of osteoarthritis pain and its relation to changes in descending inhibition. J Pharmacol Exp Ther (2013) 0.81
Effects of spinally administered adenine on dorsal horn neuronal responses in a rat model of inflammation. Neurosci Lett (2004) 0.81
Brainstem facilitations and descending serotonergic controls contribute to visceral nociception but not pregabalin analgesia in rats. Neurosci Lett (2012) 0.80
Pregabalin modulation of spinal and brainstem visceral nociceptive processing. Pain (2011) 0.80
Antinociceptive effects of lacosamide on spinal neuronal and behavioural measures of pain in a rat model of osteoarthritis. Arthritis Res Ther (2014) 0.80
Emerging drugs for neuropathic pain. Expert Opin Emerg Drugs (2014) 0.79
Nerve injury induces plasticity that results in spinal inhibitory effects of galanin. Pain (2002) 0.79
A pronociceptive role for the 5-HT2 receptor on spinal nociceptive transmission: an in vivo electrophysiological study in the rat. Brain Res (2011) 0.79
Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain. Curr Opin Support Palliat Care (2015) 0.79
The importance of the descending monoamine system for the pain experience and its treatment. F1000 Med Rep (2009) 0.79
Neuropharmacologic targets and agents in fibromyalgia. Curr Pain Headache Rep (2002) 0.78
Pains, gains, and midbrains. Proc Natl Acad Sci U S A (2005) 0.78
Superficial NK1 expressing spinal dorsal horn neurones modulate inhibitory neurotransmission mediated by spinal GABA(A) receptors. Neurosci Lett (2007) 0.77
The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain. Pain (2015) 0.77
Superficial dorsal horn neurons with double spike activity in the rat. Neurosci Lett (2007) 0.77
What do monoamines do in pain modulation? Curr Opin Support Palliat Care (2016) 0.76
Dimethylarginine dimethylaminohydrolase 1 is involved in spinal nociceptive plasticity. Pain (2015) 0.76
Descending serotonergic facilitation mediated by spinal 5-HT3 receptors engages spinal rapamycin-sensitive pathways in the rat. Neurosci Lett (2010) 0.75
Effects of lacosamide, a novel sodium channel modulator, on dorsal horn neuronal responses in a rat model of neuropathy. Neuropharmacology (2009) 0.75
Genes, molecules and patients--emerging topics to guide clinical pain research. Eur J Pharmacol (2013) 0.75
What the brain tells the spinal cord. Pain (2016) 0.75
Descending controls: insurance against pain? Pain (2011) 0.75
Pain: nonmalignant disease. Curr Opin Support Palliat Care (2014) 0.75
Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain. Pain (2017) 0.75
An introduction to Current Opinion in Supportive and Palliative Care. Curr Opin Support Palliat Care (2007) 0.75